Palatin Technologies, Inc.
AMEX:PTNBiotechnology
-$0.10 today
- Market cap
- $236.39M
- Beta
- 0.94
- P/E (TTM)
- -1.9
- EPS (TTM)
- -$6.43
Volume 0.02M
Average 1.78M
Returns on capital
Palatin Technologies, Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
362.3%
avg 2587.5%
ROIC
378.5%
avg -389.6%
ROA
-529.8%
avg -142.8%
Analysis
ROIC is currently the strongest return metric at 378.5% versus its period average of -389.6%. 2 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Stephen T. Wills | Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer & Secretary | USD 1.1M | 69 | 63.79K | 0.25% |
Carl Spana | Co-Founder, President, Chief Executive Officer & Director | USD 1.07M | 64 | 64.90K | 0.25% |
John Dodd | Senior Vice President of Preclinical Development | — | — | — | — |
Robert Jordan | Senior Vice President of Program Operations | — | — | — | — |
Stephen A. Slusher | Chief Legal Officer | — | — | — | — |
James E. Hattersley | Senior Vice President of Business Development | — | 66 | — | — |
Burns McClellan | Vice President of Investor Relations | — | — | — | — |
Michael Raizman | Chief Medical Officer | — | — | — | — |
Compensation is shown in the reported currency; data updated Jun 18, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Jul 15, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
1
$9,460.53
Net Transaction Value
−$9,460.53
Net selling
Most Active
WILLS STEPHEN T
1 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Dec 24, 25Dec 24, 2025 | WILLS STEPHEN T Direct | Sell | $9.5K$9,460.53 |
Summary
Insiders reported 0 buys worth $0.00 and 1 sells worth $9,460.53 over the last 12 months. That adds up to net selling of $9,460.53. WILLS STEPHEN T was the most active insider with 1 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | N/A1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Competitors
Who does Palatin Technologies, Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Competitors
Peer companies in the same sector
Questions
Management questions
Common questions about PTN's management, answered from reported figures.
Who manages PTN?
Palatin Technologies, Inc. (PTN) lists 8 active executives. The top listed executive is John Dodd, Senior Vice President of Preclinical Development.
Are PTN insiders buying or selling?
Recent insider activity shows net buying of $460.80M.
Continue the stock analysis
Jump to another research area for this company.